Tokyo, Japan

Aya Ishikawa

This inventor holds 1 USPTO granted patent. Top assignee: Nippon Kayaku Kabushiki Kaisha. Active years: 1997.


% Patents Active = 100.0

Average Co-Inventor Count = 7.0

ph-index = 1


Company Filing History:


Years Active: 1997

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Aya Ishikawa: Innovator in Pharmaceutical Chemistry

Introduction

Aya Ishikawa is a prominent inventor based in Tokyo, Japan. She has made significant contributions to the field of pharmaceutical chemistry, particularly through her innovative processes in drug development. Her work is characterized by a focus on creating effective medicinal compounds.

Latest Patents

Aya Ishikawa holds a patent for a process related to the preparation of 6,7-diacyl-7-deacetylforskolin derivatives. This invention involves a method for synthesizing a compound represented by a specific general formula. The process includes eliminating the acyl group at position 1 in a triacylforskolin derivative through solvolysis. The resulting compound is anticipated to have medicinal applications, showcasing her commitment to advancing healthcare solutions. She has 1 patent to her name.

Career Highlights

Throughout her career, Aya has demonstrated exceptional skill and dedication in her research. Her innovative approach has led to advancements in the preparation of pharmaceutical compounds. She is recognized for her contributions to the scientific community and her role in enhancing drug development processes.

Collaborations

Aya Ishikawa has collaborated with notable colleagues, including Tochiro Tatee and Chikara Komuro. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas in the field of pharmaceutical research.

Conclusion

Aya Ishikawa is a remarkable inventor whose work in pharmaceutical chemistry has the potential to impact medicine significantly. Her innovative processes and collaborations highlight her dedication to advancing healthcare solutions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…